Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
- 20 September 2011
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 42 (5), 967-980
- https://doi.org/10.1017/s0033291711001905
Abstract
Symptom dimensions have not yet been comprehensively tested as predictors of the substantial heterogeneity in outcomes of antidepressant treatment in major depressive disorder. We tested nine symptom dimensions derived from a previously published factor analysis of depression rating scales as predictors of outcome in 811 adults with moderate to severe depression treated with flexibly dosed escitalopram or nortriptyline in Genome-based Therapeutic Drugs for Depression (GENDEP). The effects of symptom dimensions were tested in mixed-effect regression models that controlled for overall initial depression severity, age, sex and recruitment centre. Significant results were tested for replicability in 3637 adult out-patients with non-psychotic major depression treated with citalopram in level I of Sequenced Treatment Alternatives to Relieve Depression (STAR*D). The interest-activity symptom dimension (reflecting low interest, reduced activity, indecisiveness and lack of enjoyment) at baseline strongly predicted poor treatment outcome in GENDEP, irrespective of overall depression severity, antidepressant type and outcome measure used. The prediction of poor treatment outcome by the interest-activity dimension was robustly replicated in STAR*D, independent of a comprehensive list of baseline covariates. Loss of interest, diminished activity and inability to make decisions predict poor outcome of antidepressant treatment even after adjustment for overall depression severity and other clinical covariates. The prominence of such symptoms may require additional treatment strategies and should be accounted for in future investigations of antidepressant response.Keywords
This publication has 60 references indexed in Scilit:
- Early and Delayed Onset of Response to Antidepressants in Individual Trajectories of Change During Treatment of Major DepressionThe Journal of Clinical Psychiatry, 2011
- Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptylineJournal of Affective Disorders, 2011
- Remission Prognosis for Cognitive Therapy for Recurrent Depression Using the Pupil: Utility and Neural CorrelatesBiological Psychiatry, 2011
- Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose AntidepressantsNeuropsychopharmacology, 2009
- When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D StudyNeuropsychopharmacology, 2009
- Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and DepressionBiological Psychiatry, 2008
- Measuring depression: comparison and integration of three scales in the GENDEP studyPsychological Medicine, 2007
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant ActionArchives of General Psychiatry, 2006
- Power considerations when a continuous outcome variable is dichotomizedJournal of Biopharmaceutical Statistics, 1998
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979